The present application is a National Phase of International Application PCT/CN2009/073664, filed Sep. 1, 2009.
The invention relates a Chinese herbal medicine composition used for antiinflammation, detumescence and acesodyne; and more specifically, to a Chinese herbal medicine extractive used for antiinflammation, detumescence and acesodyne and a preparation method and use thereof
The life of modern people has become more and more stress and busy, they have not much time to do exercises, and they always stand or sit, thus modern people often have many civilization diseases, such as nerve or bones and muscles inflammation, muscle ache and so on. If lacking treatment, the result is that vicious circle forms, qi and blood can not circulate smoothly.
From the earliest times, it has been several thousand years since Chinese people used Chinese herbal medicine to treat diseases. All the time, they apply the method of consolidating the constitution and resisting the pathogen to cure foreign diseases, and solve the intrinsic inflammation or ache, which make Chinese herbal medicine continue today.
At present, workers in Chinese herbal medicine industry still develop Chinese herbal medicine patch. The Chinese herbal medicine patch is convenient for external use, what is needed is only to place Chinese herbal medicine patch on the skin of area which suffers from pain or discomfort, and efficacy can work by making the ingredients in Chinese herbal medicine patch penetrate into the skin of body.
Panchrest plaster has been used for curing the symptoms of body ache and discomfort etc. since ancient times, therefore efficacy has been confirmed for a long time, the formula is composed of 17 kinds of medicinal materials, such as Radix Aconiti, Momordica Cochinchinensis, Radix Aconiti Kusnezoffii, Radix Rehmanniae, Ampelopsis Japonica, Rhizoma Bletillae, Cortex Cinnamon, Radix Angelicae Formosanae, Radix Angelicae Sinensis, Radix Paeoniae Rubra, Rhizoma Notopterygii, Radix Sophorae Flavescentis, Radix Linderae, Glycyrrhiza, Radix Angelicae Pubescentis, Radix Scrophulariae, Radix Et Rhizoma Rhei. However, a part of medicinal materials in the above formula, such as Radix Aconiti, Momordica Cochinchinensis, Radix Aconiti Kusnezoffii, have been verified to be toxic and have dermal irritation, which may cause skin discomfort after using, as showed in Table 1.
Cochinchinensis and Radix Aconiti Kusnezoffii
Momordica
Momordica
Cochinchinensis
Cochinchinensis
Carmichaelii (Radix Aconiti Kusnezoffii) extract by oral
Carmichaelii by intraperitoneal injection was 1.62 ± 1.1 mg/kg,
Additionally, Panchrest plaster from ancient formula mainly applies oleum sesami to extract the effective ingredients, which can destroy the ingredients in medicinal materials because of high temperature, or lead to the incomplete extraction of the effective ingredients, it is not easy to manage and when molding, due to add lots of zinc oxide, the problem of heavy metal residue is caused.
Therefore, it is necessary to provide a Chinese herbal medicine composition used for antiinflammation, detumescence and acesodyne, so as to solve the above problems.
The present invention provides a Chinese herbal medicine composition used for antiinflammation, detumescence and acesodyne, comprising a first type of medicinal materials and a second type of medicinal materials, wherein the first type of medicinal materials include Rhizoma Bletillae, Cortex Cinnamomi, Radix Angelicae Formosanae, Radix Angelicae Sinensis, Paeonia Lactiflora, Rhizoma Notopterygii, Radix Linderae, Glycyrrhizae, Radix Angelicae Pubescentis, and Radix Et Rhizoma Rhei, the second type of medicinal materials is one, two or three selected from the group consisting of Zingiber Officinale, Olibanum and Myrrha.
The present invention further provides a Chinese herbal medicine extractive, prepared by a process comprising the following steps: providing a first type of medicinal materials and a second type of medicinal materials, wherein the first type of medicinal materials include Rhizoma Bletillae, Cortex Cinnamomi, Radix Angelicae Formosanae, Radix Angelicae Sinensis, Paeonia Lactiflora, Rhizoma Notopterygii, Radix Linderae, Glycyrrhizae, Radix Angelicae Pubescentis, and Radix Et Rhizoma Rhei, which are basic medicinal materials, and the second type of medicinal materials is one, two or three selected from the group consisting of Zingiber Officinale, Olibanum and Myrrha, which are added medicinal materials; adding the first type of medicinal materials and the second type of medicinal materials into a container with organic solvent, making the percent by weight of the first and second type of medicinal materials with the organic solvent reach 1:N, so as to form a first mixed solution, wherein N is a number between 3 and 12; heating the first mixed solution to a first predetermined temperature and performing the extraction for a first predetermined time, so as to carry out first extraction, filtering the first mixed solution while hot, to achieve filtrate from the first extraction.
The present invention further provides a preparation method of a Chinese herbal medicine extractive, wherein the preparation method comprises the following steps: providing a first type of medicinal materials and a second type of medicinal materials, wherein the first type of medicinal materials include Rhizoma Bletillae, Cortex Cinnamomi, Radix Angelicae Formosanae, Radix Angelicae Sinensis, Paeonia Lactiflora, Rhizoma Notopterygii, Radix Linderae, Glycyrrhizae, Radix Angelicae Pubescentis, and Radix Et Rhizoma Rhei, which are basic medicinal materials, and the second type of medicinal materials is one, two or three selected from the group consisting of Zingiber Officinale, Olibanum and Myrrha, which are added medicinal materials; adding the first and second type of medicinal materials into a container with organic solvent, making the percent by weight of the first and second type of medicinal materials with the organic solvent reach 1:N, so as to form a first mixed solution, wherein N is a number between 3 and 12; heating the first mixed solution to a first predetermined temperature and performing the extraction for a first predetermined time, so as to carry out a first extraction, filtering the first mixed solution while hot achieving a filtrate from the first extraction.
The present invention further provides an use of the Chinese herbal medicine composition, for example, the Chinese herbal medicine composition is used for Chinese herbal medicine patch, Chinese herbal medicine paste and oral preparation.
The present invention provides a Chinese herbal medicine composition used for antiinflammation, detumescence and acesodyne, which does not comprise Radix Aconiti, Momordica Cochinchinensis, Radix Aconiti Kusnezoffii, Radix Rehmanniae, Ampelopsis Japonica, Radix Sophorae Flavescentis, Radix Scrophulariae. Thus, the Chinese herbal medicine composition used for antiinflammation, detumescence and acesodyne according to the present invention, is completely different from original formula of panchrest plaster. Moreover, it has been verified that Radix Aconiti, Momordica Cochinchinensis, Radix Aconiti Kusnezoffii have toxicity and dermal irritation; therefore, the Chinese herbal medicine composition according to the present invention does not have defects which original formula of panchrest plaster has. Additionally, compared with original formula of panchrest plaster, the Chinese herbal medicine composition according to the present invention further comprises the added medicinal materials (such as Zingiber Officinale, Olibanum and Myrrha) so as to enhance efficacy.
The present invention chooses effective Chinese herbal medicine which has no irritation and anaphylaxis on skin and body, and applies special extraction and preparation method and animal test methods to verify the efficacy of antiinflammation, detumescence and acesodyne, which is different from the traditional panchrest plaster and commercial Chinese herbal medicine patch. The invention is illustrated in detail combined with figures below.
The invention provides a Chinese herbal medicine composition; the composition comprises a first type of medicinal materials and a second type of medicinal materials. Wherein, the first type of medicinal materials include Rhizoma Bletillae, Cortex Cinnamomi, Radix Angelicae Formosanae, Radix Angelicae Sinensis, Paeonia Lactiflora (such as Radix Paeoniae Rubra), Rhizoma Notopterygii, Radix Linderae, Glycyrrhizae, Radix Angelicae Pubescentis, and Radix Et Rhizoma Rhei, which are basic medicinal materials. The second type of medicinal materials is one, two or three selected from the group consisting of Zingiber Officinale, Olibanum and Myrrha, which are added medicinal materials. Specifically, the Chinese herbal medicine composition according to the present invention includes seven kinds of combinations of medicinal materials as shown in Table 2.
Paeonia
Sinensis
Lactiflora
Zingiber
Glycyrrhizae
Officinale
When the second type of medicinal materials is one selected from the group consisting of Zingiber Officinale, Olibanum and Myrrha, the Chinese herbal medicine composition contains 11 kinds of medicinal materials, percent by weight of each medicinal material is in the range of 9.09%±5%. When the second type of medicinal materials is two selected from the group consisting of Zingiber Officinale, Olibanum and Myrrha, the Chinese herbal medicine composition contains 12 kinds of medicinal materials, percent by weight of each medicinal material is in the range of 8.33%±5%. When the second type of medicinal materials is three selected from the group consisting of Zingiber Officinale, Olibanum and Myrrha, the Chinese herbal medicine composition contains 13 kinds of medicinal materials, percent by weight of each medicinal material is in the range of 7.69%±5%.
In the present invention, the first type of medicinal materials is basic medicinal materials, and the second type of medicinal materials is added medicinal materials. 7 kinds of combinations of medicinal materials in Table 2 all have efficacy of the invention. In the context below, only take the seventh combination for example, which comprises 13 kinds of medicinal materials in the Chinese herbal medicine composition (that is, Rhizoma Bletillae, Cortex Cinnamomi, Radix Angelicae Formosanae, Radix Angelicae Sinensis, Paeonia Lactiflora, Rhizoma Notopterygii, Radix Linderae, Glycyrrhizae, Radix Angelicae Pubescentis, Radix Et Rhizoma Rhei, Zingiber Officinale, Olibanum and Myrrha), the other 6 combinations can be carried out in the similar means, so it is not necessary to give more details here.
Table 3 shows the comparison between the formula of the Chinese herbal medicine composition used for antiinflammation, detumescence and acesodyne according to one embodiment of the present invention and original formula of panchrest plaster.
Momordica
Ampelopsis
Cochinchinensis
Kusnezoffii
Rehmanniae
Japonica
Sinensis
Paeonia
Zingiber
Sinensis
Lactiflora
Glycyrrhizae
Officinale
The Chinese herbal medicine composition used for antiinflammation, detumescence and acesodyne of the present invention does not comprise Radix Aconiti, Momordica Cochinchinensis, Radix Aconiti Kusnezoffii, Radix Rehmanniae, Ampelopsis Japonica, Radix Sophorae Flavescentis, Radix Scrophulariae. Thus, the Chinese herbal medicine composition used for antiinflammation, detumescence and acesodyne according to the present invention, is completely different from original formula of panchrest plaster. Moreover, it has been verified that Radix Aconiti, Momordica Cochinchinensis, Radix Aconiti Kusnezoffii have toxicity and dermal irritation; therefore, the Chinese herbal medicine composition according to the present invention does not have defects which original formula of panchrest plaster has. Additionally, compared with original formula of panchrest plaster, the Chinese herbal medicine composition according to the present invention further comprises the added medicinal materials (such as Zingiber Officinale, Olibanum and Myrrha) so as to enhance efficacy.
The Chinese herbal medicine composition used for antiinflammation, detumescence and acesodyne according to the present invention, the efficacy of medicinal materials recorded in the literature is shown in Table 4.
Glycyrrhiza polysaccharide:
Glycyrrhiza
uralensis Fisch
Glycyrrhiza flavonoids:
Glycyrrhiza flavonoids
Glycyrrhiza Liquiritin
Zingiber
Officinale
zingiber Officinale by
Zingiber Officinale extractive
zingiber Officinale can inhibit
Officinale can reduce amount
Paeonia
Lactiflora
Paeonia
lactiflora
dysenteriae, pseudomonas
aeruginosa, staphylococcus
aureus, and damage the effect
dysenteriae, typhoid bacillus
coli, paratyphoid bacillus,
angelica
pseudomonas aeruginosa and
dahurica,
proteus, choleraic vibrio etc..
angelica
dahurica
staphylococcus, pseudomonas
aeruginosa and colibacillus.
bacillus, escherichia coli,
pseudomonas aeruginosa, and
The Chinese herbal medicine extractive of the present invention can be prepared by the process according to the first embodiment of the present invention. As shown in
The Chinese herbal medicine extractive of the present invention can be prepared by the process according to the second embodiment of the present application. As shown in
As shown in
As shown in
As shown in
Furthermore, the Chinese herbal medicine extractive of the present invention can be used for oral preparation, which can be divided into powder, pills and lozenge. In the embodiment, the oral preparation comprises diluent and the extractum of the Chinese herbal medicine extractive of the present application. The extractum of the Chinese herbal medicine extractive (intermediate product) is mixed with the diluent, so as to form the oral preparation (final product). As for the powder and pills, the diluent comprises starch and saccharides (such as sugar or honey); as for the lozenge, the diluent mainly comprises crystalline cellulose. The oral preparation has a content of the Chinese herbal medicine extractive in the range of 3-250 mg/g.
Additionally, the above-mentioned Chinese herbal medicine extractive comprises the following 9 types of main indicative ingredients: Paeoniflorin, Ferulic acid, Cinnamaldehyde, Glycyrrhizin, Rhein, Imperatorin, Osthol, Isoimperatorin and Gingerol. Based on 1 g of the Chinese herbal medicine extractive, the content of the indicative ingredients is respectively that, Paeoniflorin is 4.466-1.488 mg, Ferulic acid is 0.382-0.127 mg, Cinnamaldehyde is 2.159-0.720 mg, Glycyrrhizin is 9.677-3.226 mg, Rhein is 1.013-0.338 mg, Imperatorin is 0.727-0.242 mg, Osthol is 1.389-0.463 mg, Isoimperatorin is 0.709-0.236 mg, Gingerol is 0.144-0.432 mg.
The invention is further illustrated by the following test examples and test data.
The irritant of each extractum of the Chinese herbal medicine on animal skin is tested.
The each medicinal material in original formula of Panchrest plaster and the formula of the Chinese herbal medicine composition in the present invention is respectively put in an extractor with 95 wt % ethanol at a ratio of 1:8 by weight, and is extracted for 3 h at 80° C., the extractive is repeated twice, two parts of extracting solution are collected, then filtrated separeately, the filtrate is condensed by a reduced pressure concentrator. 25 μL of the extractum, positive control and negative control substance is respectively applied to the skin of an animal eliminated the hair on the back. After irritation for 24 h, the skin reaction is observed and recorded after 24 h, 48 h and 72 h. According to the dermal irritation scoring system evaluation method (as shown in Table 5) and Primary Dermal Irritation Index (as shown in Table 6), the degree of dermal irritation is evaluated (as shown in Table 7).
Momordica
Cochinchinensis
Ampelopsis
Japonica
Glycyrrhiza
Kusnezoffii
Sinensis
As shown in Table 7, although a part of medicinal materials in the Chinese herbal medicine composition of the present invention have mild irritation, the extractum of the present invention is nonirritant. However, panchrest plaster has moderate irritant.
Thirteen kinds of medicinal materials in the Chinese herbal medicine composition formula in the present invention are mixed at equal proportion or various proportion, and extracted and condensed at different conditions (temperature, organic solvent), then detected by high performance liquid chromatography (HPLC) after proper dilution, and the content of indicative ingredients (Paeonia Lactiflora, Radix Angelicae Sinensis, Cortex Cinnamomi, Glycyrrhizae, Radix Et Rhizoma Rhei, Radix Angelicae Formosanae, Radix Angelicae Pubescentis, Rhizoma Notopterygii) is calculated respectively, by comparing the extraction results of medicinal materials under different conditions, the optimal medicinal materials extraction condition is optimized. The result is shown in Table 8.
The average content of the indicative ingredients by milligram in 1 g of the extracting solution of medicinal materials by HPLC under different conditions (n=3), the result is shown in Table 9. As can be seen from Table 9, the 95 wt % to 50 wt % of ethanol or higher temperature is used; more indicative ingredients can be achieved by extracting.
1 g of each kind of medicinal materials is respectively put into an extractor with 8 g of 95 wt % ethanol, and extracted for 3 h at 80° C., the extraction is repeated twice, and two parts of extracting solution are collected, then filtered separately, the obtained filtrate is condensed into extractum by a reduced pressure concentrator, and then quantified to 150.0 mL by adding methanol (MeOH) as test solution. The high performance liquid chromatography analysis is performed by injecting 10 μL of the test solution, and then the fingerprints as shown in
Wherein,
1 g of each kind of medicinal materials in the Chinese herbal medicine composition formula of the present invention is mixed each other and to obtain 13 g mixture, the mixture is added into an extractor with 104 g of 95wt % ethanol, then extracted for 3 h at 80° C., and filtered and the filtrate is achieved, the resulted residue is treated by the above-mentioned procedure again, two parts of extracting solution are collected and filtered, and the filtrate is condensed into an extractum by a reduced pressure concentrator, and then quantified into 150.0 mL by adding methanol (MeOH) as test solution. The high performance liquid chromatography analysis is performed by injecting 10 μL of the test solution, and then the fingerprints as shown in
Test animals are Wistar rats (weight was about 250 g). During the test, test animals can eat and drink water freely. Test sample is the extractum from the Chinese herbal medicine. Rats are killed by breaking the cervical vertebrae, and are shaved off the belly hair with electric shaver, then the belly skin is removed. The removed skin, inner of which is moisted by normal saline, is clamped between the Donor cell and Receptor cell of Transdermal Franz Cell System. The test sample is dissolved in proper solvent, then placed in the Donor cell. Receptor cell is full of normal saline (containing 20 wt % of polyethylene glycol 400). The percutaneous experiment is carried at a constant temperature of 37° C. and at a fixed stiring speed of 500 rpm, and is sampled at a time of 3 h, 6 h, 12 h, 24 h, 36 h and 72 h. The sample is injected into the high performance liquid chromatograph spectrometer to analyze the content according to the indicative ingredients of the Chinese herbal medicine patch.
The result is that, percutaneous ingredients that can be detected by HPLC is the following medicinal materials ingredients such as Radix Angelicae Sinensis, Paeonia Lactiflora and Cortex Cinnamomi and so on, which contains the above three indicative ingredients. The HPLC fingerprint is shown in
(1) Mice Acetic Acid Writhing Test Method
Principle: if the animals are stimulated by chemical substances, for example, apply acetic acid, bradykinin or K+ etc. by intraperitoneal injection to stimulate peritoneum or contact skin, in order to induce pain reaction in the chemical sensitivity acceptor, and show writhing behaviors such as abdomen shrinkage invagination, hind limb extension, body torsion or worming and so on.
Test animals are ICR mice (male, 6-8 weeks). During the experiment, test animals can eat and drink freely. Before the experiment, animals should fast for 24 h. Experiment is divided into three groups, which are respectively negative control group (patch containing no medicine), positive control group (commercial Indomethacin or Diclofenac sodium patch) and experiment group (using 4 different dosages of patch for the experiment), 12 mice in each group.
The mice are weighed and made numbers, then fixed the limbs to the flat plate and shaved off the belly hair. The patch (2 cm×3 cm) is adhered to the belly of mice for 3 h, then removed off (or do not remove the patch). The mice are injected with 0.6 wt % of acetic acid by intraperitoneal injection. The writhing time of mice is observed in 10 minutes and recorded the average value of writhing, the result is shown in
The result is that, the average value of writhing for the Chinese herbal medicine patch in the present invention is lower than that of the negative control group (patch containing no medicine); therefore, the Chinese herbal medicine patch in the present invention definitely has analgesic effect.
(2) Formalin Test Method
Principle: pain raction of central and peripheral nervous system can be observed in the rats and house mice applied with diluted formalin by subcutaneous injection, and Formalin licking feet experiment is set up early in 1977 by Dubuisson and Dennis, the experiment is a kind of effective and reliable model for the selection of most of analgesic drugs. If people is applied with formalin by subcutaneous injection, formalin can cause strong and acute burning sensation after 4-5 minutes, in the following 30-60 minutes, continuous pain occurs. If house mice are applied with formalin, they may lick their feet or stamp their feet because feet is stimulated by formalin to produce pain, the licking feet time taken by initial pain caused by the injected formalin in 0-5 minutes is called early stage, pain reaction is mainly caused by substance P and bradykinin released through directly irritating pain reaction acceptor. The licking feet time consumed in 15-40 minutes is called later stage, which is mainly caused by some chemical transmitters such as histamine, serotonin, prostaglandin and kinin etc., released from the damaged cells due to inflammatory reaction. In all, licking feet behavior caused by pain of white mice induced by formalin, can evaluate effectively activity and mechanism of analgesic treating inflammatory and noninflammatory pain. Additionally, pain reaction caused by formalin, concentration of which is an important factor. When the concentration of formalin is in the range of 0.02-0.2 wt %, it can only induce licking feet reaction in early stage, identified by optical microscope, and the change is slight, when the concentration of formalin is 1 wt % or more, it can induce licking feet reaction in early stage and later stage, when the concentration of formalin is 5 wt %, acute inflammatory reaction, damage and swelling of granulocytes can be seen from histological identification after 30 minutes.
Test animals are ICR white mice (male, 6-8 weeks). During the experiment, test animals can eat and drink freely. Before the experiment, animals should fast for 24 h. Experiment is divided into three groups, which are respectively negative control group (patch containing no medicine), positive control group (commercial Indomethacin or Diclofenac sodium patch) and experiment group (using 4 different dosages of patch for the experiment), 12 mice in each group.
The white mice are weighed and made numbers. The patch (2 cm×3 cm) is cut into four equal parts, then adhered to the instep of mice, and then fixed with breathable tape. The patch is removed after 3 h, and the mice are applied with 20 μL of 1 wt % freshly formalin solution on instep by subcutaneous injection. The licking feet time during 0-5 minutes and 15-40 minutes is calculated, and the result is shown in
The result is that, licking feet time for the Chinese herbal medicine patch in the present invention is lower than that of the negative control group (patch containing no medicine); therefore, the Chinese herbal medicine patch in the present invention definitely has analgesic effect.
Principle: edema caused by injecting γ-carrageenin into plantar is a biphasic effect, after injected with γ-carrageenin, different substances can be released to induce inflammation and swelling in different time period, that is to say, histamine, serotonin and platelet activating factor (PAF) can be released in the time period of 0-1.5 h or 20 minutes to 1 h (the first stage), and kinin can be released in the time period of 1.5-2.5 h (the second stage), then prostaglandin and leukotriene can be released after 2.5 h (the third stage), leading to inflammation and swelling.
Test animals are SD white rats (male, 6-8 weeks). During the experiment, test animals can eat and drink freely. Before the experiment, animals should fast for 24 h. Experiment is divided into three groups, which are respectively negative control group (patch containing no medicine), positive control group (commercial Indomethacin or Diclofenac sodium patch) and experiment group (using 4 different dosages of patch for the experiment), 8 rats in each group.
The white rats are weighed and made numbers, drawn a measuring line on the plantar of white rats with sighning pen. The volume of the plantar is firstly measured by a swelling tester. The white rats are dresses with corset elastic bandage to avoid the Chinese herbal medicine patch bited by the white rats. of the white rats in each group are applied with 0.1 mL of Carrageenan (10 mg/mL in saline) by subcutaneous injection in plantar. The Chinese herbal medicine patch (2 cm×3 cm) are adhered to the plantar for positive control group and experiment group, and fixed with breathable tape, swelling percent is measured in the time of 0 h, 2 h, 4 h, 6 h and 24 h with a swelling tester (changing the Chinese herbal medicine patch after determining in different time). Observing the swelling condition in different time and draw swelling curve of experiment group and comparison group, identifying if it is of biometrical differences, as shown in
The result is that, swelling percent for the Chinese herbal medicine patch in the present invention is lower than negative control group (patch containing no medicine); therefore, the Chinese herbal medicine patch in the present invention definitely has antiinflammation and detumescence effect.
Although the present invention has described the above examples, these examples do not use to define the present invention, a person skill in the art with common knowledge of this field can make various changes and modification without departing from the spirit of the present invention. Thus, the protection scope of the present invention should be that defined by the claims.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/CN2009/073664 | 9/1/2009 | WO | 00 | 3/1/2012 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2011/026267 | 3/10/2011 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
6607756 | Rosenstiel | Aug 2003 | B1 |
Number | Date | Country |
---|---|---|
2216416 | Jan 1996 | CN |
1273837 | Nov 2000 | CN |
1401360 | Mar 2003 | CN |
101002900 | Jul 2007 | CN |
2009021644 | Mar 2009 | KR |
Entry |
---|
International Search Report for PCT/CN2009/073664 dated May 27, 2010. |
Number | Date | Country | |
---|---|---|---|
20120164249 A1 | Jun 2012 | US |